|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs显示文摘 | Khosravan R Wu J T Joseph Ridge N | | 0，，08： | 1 |
| 2 | Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat,a non-purine selective inhibitor of xanthine oxidase显示文摘 | Grabowski B Khosravan R Wu J T | | 0，，01： | 1 |
| 3 | Pharmaco- kinetics and pharmacodynamics of febuxostat, a new non - purine selective inhibitor of xanthine oxidase in subjects with renal impair- ment显示文摘 | MAYER M D KHOSRAVAN R VERNILLET L el al | 2005 | Am J Wher2005，12，1： | 1 |
| 4 | Pharmacokineties, pharmacodynamlcs and safety of febuxostar, a non- purine selective inhibitor of xanthine oxidase, in a close escalation study in healthy subjects显示文摘 | Khosravan R Grabowski BA Wu JT | 2006 | Clin Pharmacoki net2006，45，8： | 1 |
| 5 | Pharmacokinetics and pharmacodynamics of febuxostat, a new non-purine selective inhi- bitor ofxanthine oxidase in subjects with renal impairment 显示文摘 | Mayer MD Khosravan R Vemillet L | 2005 | Am J Ther2005，12，1： | 1 |
| 6 | The effect of age and gender on pharmacokineties, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase 显示文摘 | Khosravan R Kukulka MJ Wu JT | 2008 | J Clin Pharmacol2008，48，9： | 1 |
| 7 | Pharmacokinetics,pharmacodynamics and safety of febuxostat,anon-purine selective inhibitor of xanthine oxidase,in a dose escalation study in healthy subjects显示文摘 | KHOSRAVAN R GRABOWSKI B A WU J T | 2006 | Clin Pharmacokinet2006，45，8： | 1 |
| 8 | Febuxostat (TMX-67), a novel, nonpurine, selective inhibitor of xanthine oxidase, is safe and decreasesserum urate in healthy volunteers 显示文摘 | Becker MA Kisicki J Khosravan R | 2004 | Nucleosides Nucleotides Nucleic Acids2004，23，8： | 1 |
| 9 | Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects 显示文摘 | Khosravan R Grabowski BA Wu JT | 2006 | Clin Pharmacokinet2006，45，8： | 1 |
| 10 | Febuxostat ( TMX - 67), a novel, non - purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers显示文摘 | Becker MA Kisicki J Khosravan R | 2004 | Nucleosides Nucleotides Nucleic Acids2004，89，： | 1 |
| 11 | Effect of food or antacid on pharmacokinetics and pharmaco - dynamics of febuxostat in healthy subjects显示文摘 | Khosravan R Grabowski B Wu JT | 2008 | B J Clin Pharrtwol2008，65，： | 1 |
| 12 | Pharmacokinetics,pharmacodynamics and safety of febuxostat,a non-purine selective inhibitor of xanthine oxidase,in a dose escalation study in healthy subjects显示文摘 | Khosravan R Gra Bowski Ba WU JT | 2006 | Clin Pharmacokinet2006，45，8： | 1 |
| 13 | Pharmaco- kinetics, pharmacodynamics and safety of febuxostat, a non-pu- rine selective inhibitor of xanthine oxidase, in a dose escalation study in heahhy subjects 显示文摘 | KHOSRAVAN R GRA BOWSKI BA WU JT | 2006 | Clin Pharmacokinet2006，45，8： | 1 |
| 14 | Metabolism and excretion of febuxostat, a novel non-purine selective inhibitor of xanthine oxidase, in healthy male subjects 显示文摘 | GRABOWSKI BA VERNILLET L KHOSRAVAN R | 2005 | Drug Metab Rev2005，37，2： | 1 |
| 15 | Pharma- cokinetics and pharmacodynamics of febuxostat, a new selective nonpurine inhibitor of xanthine oxidase, in subjects with renal impairment显示文摘 | MAYER MD KHOSRAVAN R VERNILLET L | 2005 | Am J Ther2005，12，1： | 1 |
| 16 | The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase显示文摘 | KHOSRAVAN R KUKULKA M WU JT | 2008 | J Clin Pharmacol2008，48，： | 1 |
| 17 | Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects显示文摘 | KHOSRAVAN R GRABOWSKI B WU JT | 2008 | Br J Clin Pharmacol2008，65，3： | 1 |
| 18 | Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers 显示文摘 | BECKER MA KISICKI J KHOSRAVAN R | 2004 | Nucleosides Nucleotides Nucleic Acids2004，23，89： | 1 |
| 19 | The effect of mild and moderate hepatic impairment on pharmacokinetics, pharmacodyaamics, and safety of febnxostat, a novel non- purine selective inhibitor of xanthine oxidase 显示文摘 | KHOSRAVAN R GRABOWSKI BA MAYER MD | 2006 | J Clin Pharmacol2006，46，1： | 1 |
| 20 | Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects显示文摘 | Khosravan R Grabowski BA Wu JT | 2008 | Br J CIin Pharmacol2008，65，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员